A regulatory decision on the combination therapy is expected on February 8, 2025. The Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application (sNDA) for ...
Zoloft (sertraline), is prescribed for various mental health conditions. It is available in oral tablet and liquid solution forms. Dosing of Zoloft varies by condition and other factors, with dosage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results